ArticleFrontiers in oncology2026
Cardiometabolic comorbidities and prostate cancer risk: evidence from the prostate, lung, colorectal, and ovarian cancer screening trial.
Qian Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.